Article Versions Notes

Zhang L, Zhao G, Cheng X, Wang S, Wang J, Huai X, Xia Y, Xiao Y, Ren S, Zhang S, et al. A Phase II Random, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of a Recombinant G Protein-Based Respiratory Syncytial Virus Vaccine in Healthy Older Adults. Vaccines. 2025; 13(8):885. https://doi.org/10.3390/vaccines13080885

Zhang, Lunan, Gan Zhao, Xin Cheng, Shuo Wang, Jiarong Wang, Xuefen Huai, Yu Xia, Yanling Xiao, Sulin Ren, Shijie Zhang, and et al. 2025. "A Phase II Random, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of a Recombinant G Protein-Based Respiratory Syncytial Virus Vaccine in Healthy Older Adults" Vaccines 13, no. 8: 885. https://doi.org/10.3390/vaccines13080885

Zhang, L., Zhao, G., Cheng, X., Wang, S., Wang, J., Huai, X., Xia, Y., Xiao, Y., Ren, S., Zhang, S., Wang, Q., & Wang, B. (2025). A Phase II Random, Double-Blind, Placebo-Controlled Study of the Safety and Immunogenicity of a Recombinant G Protein-Based Respiratory Syncytial Virus Vaccine in Healthy Older Adults. Vaccines, 13(8), 885. https://doi.org/10.3390/vaccines13080885